期刊文献+
共找到1,305篇文章
< 1 2 66 >
每页显示 20 50 100
The application of nucleic acid testing (NAT) in blood screening in Shanghai
1
《中国输血杂志》 CAS CSCD 2001年第S1期282-284,共3页
关键词 ACID NAT in blood screening in Shanghai The application of nucleic acid testing
下载PDF
Correlation betweenn ucleic acid testing (NAT) and serology in routing blood screening
2
《中国输血杂志》 CAS CSCD 2001年第S1期402-,共1页
关键词 ACID NAT Correlation betweenn ucleic acid testing and serology in routing blood screening
下载PDF
The investigation of the HBsAg contamination in the blood screening laboratory and thevalidation of the effects of the disinfectant treatments
3
《中国输血杂志》 CAS CSCD 2001年第S1期337-,共1页
关键词 HBSAG The investigation of the HBsAg contamination in the blood screening laboratory and thevalidation of the effects of the disinfectant treatments
下载PDF
Application research for fully automatic blood screening in transfu sionservice
4
《中国输血杂志》 CAS CSCD 2001年第S1期407-,共1页
关键词 Application research for fully automatic blood screening in transfu sionservice
下载PDF
Screening, Treatment and Control of High Blood Pressure on Five Sites in Mali
5
作者 Mamadou Touré Sagara Ibrahima +19 位作者 Youssouf Camara Hamidou Oumar Bâ Ibrahima Sangaré Djénébou Traoré Noumou Sidibé Fousseyni Samassékou Massama Konaté Coumba Thiam Doumbia Asmaou Maiga Réné-Marie Dakouo Hamidou Camara Sako Mariam Sidibé Samba Adama Sogodogo Boubacar Diarra Boubacar Sonfo Aladji Traoré Mamadou Diakité Ilo Bella Diall Ichaka Menta 《World Journal of Cardiovascular Diseases》 CAS 2024年第5期322-332,共11页
Introduction: High blood pressure is defined as blood pressure greater than or equal to 140 mm Hg for systolic and or 90 mm Hg for diastolic. It constitutes a major public health problem, the leading chronic disease i... Introduction: High blood pressure is defined as blood pressure greater than or equal to 140 mm Hg for systolic and or 90 mm Hg for diastolic. It constitutes a major public health problem, the leading chronic disease in the world. The objective was to determine the prevalence, treatment rate and control of hypertension. Methods: This was a cross-sectional and descriptive study which took place over a period of 6 months in a hospital environment and in the general population. Results: Of the 1000 participants, 637 had hypertension, giving a prevalence of 63.70% with a female predominance. Thirty-three percent (33%) were unaware of their high blood pressure. The age group 60 and more was the most represented (44%). A proportion of 33 and 23.20 were overweight and obese participants, respectively. Male subjects were more overweight than female, unlike obesity which was more common among female subjects. Sixty-two percent (62%) of hypertensives were treated, of whom 44% were non-compliant. The excessively high cost and consumption of medications as needed were the main factors in therapeutic non-compliance. Twenty-two percent (22%) of all hypertensive patients and 35% of treated hypertensive patients were controlled. Women were more treated but less observant and less controlled than men. Therapeutic coverage and combination therapy rates were lower in rural areas. Hypertensives who had a high level of education were better treated and controlled than those who had no level. Conclusion: High blood pressure remains a real public health problem in Mali. It is more common in people aged 60 and over and in females. One in three hypertensives were unaware of their hypertension. The majority received antihypertensive treatments, but only a minority of them had their hypertension controlled. 展开更多
关键词 High blood Pressure screenING Control Rate MALI
下载PDF
Diagnostic value of fecal occult blood testing for screening colorectal cancer 被引量:3
6
作者 CHEN Kun 1, JIAO Deng Ao 1, ZHENG Shu 2, ZHOU Lun 2, YU Hai 2, YUAN Ya Chang 3, YAO Kai Yan 3, MA Xing Yuan 3 and ZHANG Yang 1 《World Journal of Gastroenterology》 SCIE CAS CSCD 1997年第3期38-40,共3页
AIM To evaluate the diagnostic value of fecal occult blood testing in mass screening for colorectal cancer. METHODS The reversed passive hemagglutination reaction fecal occult blood testing (RPHA FOBT) and colore... AIM To evaluate the diagnostic value of fecal occult blood testing in mass screening for colorectal cancer. METHODS The reversed passive hemagglutination reaction fecal occult blood testing (RPHA FOBT) and colorectal cancer′s risk factor quantitative method as the preliminary screening, and 60 cm fiberoptic colonoscopy as the accurate screening were used to detect colorectal cancer in a natural community of 75813 subjects in this study. RESULTS As compared with the 60cm fiberoptic colonoscopy as a standard reference, FOBT has a sensitivity of 41 9%, specificity of 95 8%, Youden′s index 0 38, and positive predictive value of 0 68%, these results went up with age in the subjects from the first detection. A 3 year follow up in the target mass showed that all new cases were once FOBT negative. CONCLUSION Values in FOBT as an indicator of mass screening for colorectal cancer were limited. 展开更多
关键词 COLORECTAL neoplasms/diagnosis OCCULT blood mass screenING risk factors COLONOSCOPY
下载PDF
Bioinformatics Analysis Raises Candidate Genes in Blood for Early Screening of Parkinson's Disease 被引量:1
7
作者 ZHANG Yi YAO Li +4 位作者 LIU Wei LI Wei TIAN Chan WANG Zhao Yang LIU Di 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2014年第6期462-465,共4页
Parkinson's disease (PD) is a typical degenerative disease, which is characterized by the most obvious symptoms of movement dysfunction, including shaking, rigidity, slowness of movement and difficulty in walking a... Parkinson's disease (PD) is a typical degenerative disease, which is characterized by the most obvious symptoms of movement dysfunction, including shaking, rigidity, slowness of movement and difficulty in walking and gait. This disease can not be clearly identified through laboratory tests at present, thus application of high-throughput technique in studying the expression profiles of PD helps to find the genetic markers for its early diagnosis. Studies on expression profiles of neurodegenerative diseases have revealed the novel genes and pathways involved in the progress of illness. In this study, the expression profiles of PD in blood were compared, showing that 181 differentially expressed genes (DEG) exhibit a similar expression trend both in patients and in normal controls. 展开更多
关键词 GENE Bioinformatics Analysis Raises Candidate Genes in blood for Early screening of Parkinson’s Disease GFAP PD SLC BCAM
下载PDF
The Use of Dried Blood Spot Samples in Screening Drugs of Abuse 被引量:1
8
作者 Rizwana Quraishi Raka Jain Atul Ambekar 《Pharmacology & Pharmacy》 2013年第2期152-159,共8页
The present article will provide an overview of use of dried blood sampling method for analysis of drug of abuse. Relatively short half life and instability in blood, calls for alternative sampling method for determin... The present article will provide an overview of use of dried blood sampling method for analysis of drug of abuse. Relatively short half life and instability in blood, calls for alternative sampling method for determination of drugs of abuse. Dried blood spot (DBS) method has many advantages over the conventional sampling methods. The available method for DBS sample collection, storage and transport are described here. The techniques involved in and the factors that may influence the accuracy and reproducibility of the DBS methods for determination of drugs of abuse are presented. The DBS sampling has the potential to be a useful technique to detect drugs of abuse. The use of DBS for any drug should be judged against the potential error involved with the method. 展开更多
关键词 DRIED blood SPOTS DRUGS of ABUSE screenING Review
下载PDF
Sample preference for colorectal cancer screening tests: Blood or stool? 被引量:5
9
作者 Joanne M. Osborne Carlene Wilson +3 位作者 Vivienne Moore Tess Gregory Ingrid Flight Graeme P. Young 《Open Journal of Preventive Medicine》 2012年第3期326-331,共6页
Objective: Despite the high prevalence of CRC and the proven benefits of faecal sampling tests, participation rates in CRC screening are suboptimal. Literature has identified a number of barriers to participation, inc... Objective: Despite the high prevalence of CRC and the proven benefits of faecal sampling tests, participation rates in CRC screening are suboptimal. Literature has identified a number of barriers to participation, including faecal aversion. Emerging test technologies suggest blood-based molecular markers might provide an alternative, more acceptable option, for CRC screening tests. We aim to determine preference for blood compared to faeces as the sample for the screening test. Methods: A survey was mailed to 956 South Australians aged 50 to 74 years. Data were collected on sample preference, demographic variables, and ratings of screening test convenience and comfort. Results: The survey yielded a 43% response rate. The majority of participants preferred to provide a blood sample (78% v 22%, p < 0.001). Women were more likely to prefer blood than men (82% vs 74%, p = 0.05). Sample experience influenced preferences, with a significantly higher preference for faeces among participants with experience in faecal sampling (27% vs 17% with no experience, p < 0.05). Participants who preferred to provide a faecal sample rated it significantly more convenient (p < 0.001), more comfortable (p < 0.001), and more acceptable (p < 0.001) than those who preferred blood sampling. Conclusions: Survey participants overwhelmingly indicate a preference for the idea of a blood sample over a faecal sample for CRC screening. Preference was influenced by gender, experience with sampling method and the individual’s perception of sampling convenience, sampling comfort and sample acceptability. Our results suggest population participation rates are likely to improve with blood-based screening tests. 展开更多
关键词 Colon Cancer screening FAECAL OCCULT blood Test SAMPLE PREFERENCE STOOL Sampling blood Sampling Participation
下载PDF
Nat screening blood donors in Australia:a comparison of pooled and single donation screening
10
《中国输血杂志》 CAS CSCD 2001年第S1期408-,共1页
关键词 Nat screening blood donors in Australia
下载PDF
Evaluation on the results of screening for anti-HCV of blood banks in Hubei Province
11
《中国输血杂志》 CAS CSCD 2001年第S1期404-,共1页
关键词 HCV Evaluation on the results of screening for anti-HCV of blood banks in Hubei Province
下载PDF
EVALUATION OF REVERSE PASSIVE HEMAGGLUTINATION (RPHA) FECAL OCCULT BLOOD TEST IN SCREENING OF COLORECTAL NEOPLASIA 被引量:1
12
作者 余海 周伦 +5 位作者 郑备义 邱培林 郑树 孙其荣 邵毓文 马新源 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1994年第4期274-278,共5页
A high risk population consisting of 3034 people with history of rectal polyps or ulcers were screened for colorectal neoplasia with Reverse Passive Hemagglutination Fecal Occult Blood Test (RPHA FOB) and 60 cm fibero... A high risk population consisting of 3034 people with history of rectal polyps or ulcers were screened for colorectal neoplasia with Reverse Passive Hemagglutination Fecal Occult Blood Test (RPHA FOB) and 60 cm fiberoptic colonoscopy. Among 2553 subjects (84.1%)who completed both tests, 11 cases of colorectal malignancies and 465 cases of polyps were detected.Using colonoscopic finding and histopathological examination as the 'gold standard' of diagnosis, results showed that FOB positivity of polyps was related to their size, macroscopic appearance and surface features but no correlation between bleeding of polyps and their location, numbers, pathological types were found. In this study the sensitivity of RPHA in screening of colorectal malignancy was 63.6% (7/11), while that for polyps was only 21.1% (98/465) . For screening of colorectal neoplasia (cancer+polyps) the overall sensitivity and specificity of RPHA FOB were 22.1% and 82.4%, the positive and negative predictive values were 22.3% and 82.2% respectively. Amoug 465 polyps there were 195 adenomas, further analysis showed that villous and tubulovillous adenomas had higher intestinal bleeding rate (FOB positive)than tubular type (45.5%,30.0% and 17.8% respectively, X2=5.8, p=0.05). The results indicate that although the sensitivity of RPHA FOB in screening for colorectal polyps was generally low, but about 40% (8/21) of villous and tubulovillous adenoma which present higher tendency of malignant transformation can be detected by RPHA FOB as a screening Procedure. So the authors suggest that screening of colorectal neoplasia be not only a procedure of secondary prevention but also a measure of primary prevention for colorectal cancer.Accepted March 22, 1994 展开更多
关键词 Colon/Rectum neoplasia POLYPS screening Colonoscopy RPHA fecal occult blood test
下载PDF
Study on the screening result of anti-HCV in the blood donors
13
《中国输血杂志》 CAS CSCD 2001年第S1期338-,共1页
关键词 HCV Study on the screening result of anti-HCV in the blood donors
下载PDF
Ethical and Regulatory Issues with Residual Newborn Screening Dried Bloodspots
14
作者 Erin Rothwell Jeffrey R. Botkin 《Open Journal of Preventive Medicine》 2015年第10期409-415,共7页
After newborn screening is completed, most states retain leftover dried bloodspots. These dried bloodspots are stored for varying lengths of time among different state newborn screening programs. Dried bloodspots are ... After newborn screening is completed, most states retain leftover dried bloodspots. These dried bloodspots are stored for varying lengths of time among different state newborn screening programs. Dried bloodspots are a unique and valuable resource for the development of new newborn screening tests, quality assurance and biomedical research. Recent changes to the 2014 Newborn Screening Reauthorization Saves Lives Act require explicit parental consent for the retention and use of dried bloodspots in federally funded research. This has raised several ethical and regulatory issues and highlighted the challenges of respecting individual autonomy and public health goals. This article provides an overview of these issues and discusses methods for obtaining parental consent. These issues may be applicable to consent for the storage and use of biospecimens among other settings according to proposed changes to the Common Rule. 展开更多
关键词 RESIDUAL DRIED blood SPOTS (DBS) NEWBORN screening (NBS) Public Health Population Research
下载PDF
Cost-benefit analysis on pre-collection screening for HBsAg and Hb during repeated blood donors
15
《中国输血杂志》 CAS CSCD 2001年第S1期401-,共1页
关键词 HBSAG HB Cost-benefit analysis on pre-collection screening for HBsAg and Hb during repeated blood donors
下载PDF
2018—2022年京津冀血液筛查实验室检测前质量不合格标本情况分析
16
作者 胡京辉 葛红卫 +4 位作者 秦倩倩 刘正敏 韩卫 潘彤 王瑞 《北京医学》 CAS 2024年第6期513-518,共6页
目的 探讨2018—2022年京津冀15家血液筛查实验室(血站实验室)检测前质量不合格标本的情况及存在问题,为提升京津冀血站实验室质量同质化建设提供数据支持。方法 选取北京、天津和河北3个地区的血液中心和中心血站的15家血站实验室,其... 目的 探讨2018—2022年京津冀15家血液筛查实验室(血站实验室)检测前质量不合格标本的情况及存在问题,为提升京津冀血站实验室质量同质化建设提供数据支持。方法 选取北京、天津和河北3个地区的血液中心和中心血站的15家血站实验室,其中包括3家血液中心实验室和12家地市级中心血站实验室,分别用代码A~O表示。收集15家血站实验室2018—2022年检测前接收标本总数、质量不合格标本总数以及常见不合格原因(溶血、乳糜、容量不足量、血细胞比容异常、采集后未按要求及时离心和其他原因等)对应标本数,分析检测前标本的不合格情况。结果2018—2022年15家血站实验室检测前质量不合格标本率为1.98‱,呈下降趋势,由2.54‱下降至1.57‱。标本质量不合格原因5年来保持稳定,占比依次是乳糜(74.72%)、溶血(7.41%)、容量不足量(5.42%)、其他原因(4.42%)、血细胞比容异常(4.35%)、采集后未按要求及时离心(3.68%)。15家血站实验室之间检测前质量不合格标本率的比较,差异有统计学意义(P<0.05)。与检测前总体质量不合格标本率相比,11家实验室低于总体水平,其中4家持续保持稳定状态。结论 15家血站实验室的检测前过程控制总体良好,但由于各血站在检测前标本管理过程的流程设计和工作模式的不同导致统计数据存在差异,部分实验室仍有改进空间。 展开更多
关键词 检测前过程 质量管理 血液筛查 标本
下载PDF
重庆市单采血小板献血者经血传播HIV的残余风险评估
17
作者 张巧琳 韩凤娇 +2 位作者 刘静怡 刘东 谢成兵 《检验医学与临床》 CAS 2024年第10期1484-1487,共4页
目的了解重庆地区初次、重复单采血小板献血者人类免疫缺陷病毒(HIV)的感染情况,评估血液常规筛查后仍存在的经血传播HIV的危险度,为现有血小板献血招募及血液筛查策略提供数据支持。方法收集2016-2020年重庆地区单采血小板献血者HIV项... 目的了解重庆地区初次、重复单采血小板献血者人类免疫缺陷病毒(HIV)的感染情况,评估血液常规筛查后仍存在的经血传播HIV的危险度,为现有血小板献血招募及血液筛查策略提供数据支持。方法收集2016-2020年重庆地区单采血小板献血者HIV项目的初筛和确证试验结果,分别计算重复献血者和初次献血者的HIV阳性率,并用发病率-窗口期模型进行经血传播HIV的残余风险评估。结果单采血小板献血者中,初次献血者HIV确认阳性14例,阳性率为0.155%,重复献血者确认阳性16例,阳性率为0.027%,二者间HIV确认阳性率比较,差异有统计学意义(χ^(2)=29.523,P<0.05)。对不同人口学特征的初次单采血小板献血者及重复单采血小板献血者的HIV阳性率分别进行比较,结果显示:不同年龄分组的献血者HIV阳性率比较,差异均无统计学意义(χ^(2)=3.736、1.357,P>0.05);不同性别献血者HIV阳性率比较,差异均有统计学意义(χ^(2)=5.452、4.986,P<0.05);不同学历献血者HIV阳性率比较,差异均有统计学意义(χ^(2)=18.863、12.049,P<0.05)。重复单采血小板献血者经血传播HIV的残余风险为1/275851。结论重庆地区单采血小板献血者中HIV残余风险处于较高水平,主要来源于初次献血、低学历、男性人群;加强初次献血者的前端征询、筛查,以及定期对献血者进行健康知识科普,优化固定志愿献血者队伍,可进一步降低重庆地区经血小板输注传播HIV的风险。 展开更多
关键词 单采血小板 残余风险 人类免疫缺陷病毒 血液筛查 重复献血者
下载PDF
具核梭杆菌在结直肠癌筛查中的应用价值
18
作者 施海韵 徐芳 +5 位作者 许心怡 周敏思 郭水龙 吴静 李鹏 张澍田 《临床和实验医学杂志》 2024年第12期1334-1337,共4页
目的探讨具核梭杆菌(Fn)在结直肠癌筛查中的临床价值。方法前瞻性纳入于2022年7月至2023年12月期间在首都医科大学附属北京友谊医院行结肠镜检查者。于结肠镜检查前3 d内留取粪便样本,采用定量聚合酶链反应(qPCR)法检测粪便中菌群Fn的... 目的探讨具核梭杆菌(Fn)在结直肠癌筛查中的临床价值。方法前瞻性纳入于2022年7月至2023年12月期间在首都医科大学附属北京友谊医院行结肠镜检查者。于结肠镜检查前3 d内留取粪便样本,采用定量聚合酶链反应(qPCR)法检测粪便中菌群Fn的相对丰度,同时行粪便隐血试验(FOBT)。采用受试者操作特征(ROC)曲线评估Fn对结直肠癌的诊断效能。结果共纳入271例受试者,其中诊断结直肠癌58例(21.40%)。结直肠癌组患者粪便中的Fn相对丰度显著高于非结直肠癌组[6.602(3.716,8.997)vs.1.665(0.593,4.752)],差异有统计学意义(P<0.05)。Fn诊断结直肠癌的曲线下面积(AUC)为0.750(95%CI:0.680~0.820,P<0.05),对应敏感度、特异度和阴性预测值分别为0.724、0.742和0.908。在FOBT结果阴性者中,Fn诊断结直肠癌的敏感度、特异度和阴性预测值分别为0.714、0.730和0.983。Fn联合FOBT诊断结直肠癌的AUC为0.894(95%CI:0.848~0.940,P<0.05),对应敏感度、特异度和阴性预测值分别为0.897、0.765和0.964,诊断效能显著优于单独检测Fn(P<0.05)。结论粪便Fn在结直肠癌筛查中具有较高的敏感性、特异性和阴性预测值,与FOBT联合应用可进一步提升结直肠癌检出率。因此,粪便Fn是结直肠癌筛查有价值的无创生物标志物,可有效避免FOBT阴性者中结直肠癌的漏诊。粪便Fn丰度升高者应尽快行结肠镜检查,若Fn与FOBT均阴性,则可基本排除结直肠癌。 展开更多
关键词 结直肠癌 具核梭杆菌 粪便隐血试验 筛查
下载PDF
石家庄市无偿献血者感染性指标检测不合格人群特征分析
19
作者 张静 王阳 王切 《国际检验医学杂志》 CAS 2024年第S01期34-41,共8页
目的分析石家庄市无偿献血者感染性指标检测不合格人群分布特征,以排除献血的高风险人群,为制定献血者招募策略提供理论依据。方法对2022年河北省血液中心采集的无偿献血者标本进行感染性指标[乙型肝炎病毒表面抗原(HBsAg)、丙型肝炎病... 目的分析石家庄市无偿献血者感染性指标检测不合格人群分布特征,以排除献血的高风险人群,为制定献血者招募策略提供理论依据。方法对2022年河北省血液中心采集的无偿献血者标本进行感染性指标[乙型肝炎病毒表面抗原(HBsAg)、丙型肝炎病毒抗体(抗-HCV)、人免疫缺陷病毒抗体(抗-HIV)、梅毒抗体(抗-TP)、丙氨酸氨基转移酶(ALT)、血液病毒核酸(NAT)]筛查,分析检测不合格标本的人群分布特性,并采用多因素Logistic回归分析其影响因素。结果2022年共检测献血者标本182950份,感染性指标总不合格率为1.21%。性别方面,女性无偿献血者ALT不合格率明显低于男性(P<0.05),但HBsAg、抗-HCV、抗-TP、抗-HIV四项传染性指标不合格率均明显高于男性(P<0.05);年龄方面,ALT不合格率最高者为26~35岁献血者,HBsAg和NAT不合格率最高者为36~45岁献血者,抗-HCV和抗-TP不合格率最高者为46~60岁献血者,抗-HIV为18~25岁献血者;文化程度方面,ALT、抗-HCV、抗-TP、NAT不合格率最高者均为初中文化程度献血者;职业方面,ALT、HBsAg不合格率最高者为农民,抗-TP、抗-HIV不合格率最高者为自由职业者,NAT不合格率最高者为学生和商贸职员;初次献血者的HBsAg、抗-HCV、抗-TP、抗-HIV不合格率明显高于重复献血者(P<0.05)。性别、职业、文化程度、年龄、季节、采血队、献血次数、血型是影响血液筛查阳性率的主要因素。结论献血人群感染指标阳性率分布具有性别、年龄、文化程度、职业、献血频次的分布特征,且受多种因素的影响。应将高风险人群排除在献血队伍之外,提高输血安全。 展开更多
关键词 无偿献血者 血液筛查 分布特征 回归分析 阳性率
下载PDF
武汉城市圈献血人群戊型肝炎病毒流行情况调查
20
作者 余琴 许婷婷 +1 位作者 张丽洁 赵磊 《中国输血杂志》 2024年第1期21-25,共5页
目的了解武汉城市圈无偿献血人群戊型肝炎病毒(HEV)流行情况,为献血人群HEV筛查策略的制定提供数据支撑。方法随机收集2021年1—12月武汉城市圈内实施集中化检测的4个地区(鄂州、天门、仙桃、潜江)的献血者血液标本3329份,其中ALT正常... 目的了解武汉城市圈无偿献血人群戊型肝炎病毒(HEV)流行情况,为献血人群HEV筛查策略的制定提供数据支撑。方法随机收集2021年1—12月武汉城市圈内实施集中化检测的4个地区(鄂州、天门、仙桃、潜江)的献血者血液标本3329份,其中ALT正常的无偿献血者合格血样2737份(ALT正常组),ALT升高的血样592份(ALT升高组)。采用ELISA检测抗-HEV IgG、抗-HEV IgM和HEV Ag;采用Real-time PCR对ALT升高的血样和抗-HEV IgM阳性的ALT正常血样进行HEV RNA单人份检测。采用χ^(2)检验或Fisher精确检验来评估不同地区、不同ALT水平组抗-HEV IgG和抗-HEV IgM阳性率的差异。结果4个地区3329份血液标本的抗-HEV IgG、抗-HEV IgM和HEV Ag总阳性率分别为21.63%(720/3329)、1.29%(43/3329)和0%。不同地区献血者抗-HEV IgG阳性率有差异(P<0.05)。抗-HEV IgG阳性率最高的是天门29.44%(136/462),其次分别是潜江22.69%(236/1040)、仙桃22.66%(230/1015)、鄂州14.53%(118/812)。ALT升高组献血者抗-HEV IgG阳性率和抗-HEV IgM阳性率显著高于ALT正常组献血者(25.68%vs 20.75%,2.53%vs 1.02%,均为P<0.05)。ALT水平升高组的所有血样和抗-HEV IgM阳性的合格血样均未检测到HEV RNA。结论HEV在武汉城市圈献血人群中存在流行,但现症感染率极低,且不同地区抗-HEV抗体血清流行率存在差异。ALT升高献血者抗-HEV抗体流行率显著高于ALT正常献血者。 展开更多
关键词 戊型肝炎病毒 血清学流行率 献血者 核酸检测
下载PDF
上一页 1 2 66 下一页 到第
使用帮助 返回顶部